I saw a post on Reddit (sunraydoc) and even thoug
Post# of 148087
https://www.gsk.com/en-gb/media/press-release...iv-assets/
ViiV was established in 2009 when PFE and GSK combined their assets.. Shinogi Joined in 2012. ViiV ends up buying BMS’s HIV assets in 2016. Dr. Max goes over in 2016. His LinkedIn account says he “directed integration of BMS HIV franchise into ViiV Healthcare” from 2016 to 2019. And we can assume based on his LinkedIn account that he was at ViiV all the way up until two weeks ago When he gained the global SVP title at CYDY.
He’s not just at CYDY to kick the tires. The tires have already been kicked. I think he’s there to integrate at least LL’s (CYDY) HIV programs/indications with and all versions of LL into ViiV. ViiV may also be thinking about expanding beyond HIV and into the other indications with LL.
Dr. Max is an expert at many things, but we can also say he’s an expert at merging HIV programs from multiple companies And turned those mergers into a finally oiled machine.
Seatbelts, Please.